Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours
Overview
Published in Clinical Sarcoma Research (Mangham and Athanasou, 2011), this review gives histopathologists guidelines for clinical assessment, specimen handling and diagnostic reporting of benign and malignant primary bone tumours. The same principles of specimen handling largely apply to secondary bone tumours.
A multidisciplinary approach
Before handling a specimen, the pathologist should review information from radiology, surgical, oncology and other clinical colleagues. Close cooperation across specialties is essential, and all primary malignant bone tumours should be discussed at a properly constituted sarcoma multidisciplinary team meeting.
What the guidance covers
The document addresses classification, grading and staging of primary bone tumours, which vary widely in clinical behaviour and pathological features. It sets out a structured approach to handling biopsy and resection specimens and to histological reporting, so that the report provides the information needed to plan treatment.
Consistency and quality
Using consistent terminology and report content supports communication at multidisciplinary meetings, collaboration between cancer units and networks, and a shared database for auditing clinical, radiological and pathological aspects of bone tumours. Because many bone tumours are uncommon or rare, the authors stress the need for experience in orthopaedic pathology and recommend participation in an external quality assessment scheme that includes bone tumour pathology.
Why it matters
Primary bone tumours are rare, and their diagnosis depends on correlating histological findings with clinical and imaging information. A structured, standardised approach reduces the risk of misdiagnosis and ensures that reports contain the details surgeons and oncologists need to plan treatment.
Who it is for
Histopathologists, orthopaedic oncology surgeons, radiologists and members of sarcoma multidisciplinary teams.